NICE has recommended two of GW Pharma's cannabis-based medicines, the first time that medicines derived from the plant have been recommended for NHS funding.
Drug prices have become an issue in the UK’s general election, after Labour leader Jeremy Corbyn accused the Conservatives of planning a shady deal with Donald Trump that would see the NHS
